268 related articles for article (PubMed ID: 20647569)
21. [Mechanism of leukemogenesis by human T-cell leukemia virus type I: from infection with HTLV-I to the onset of adult T-cell leukemia].
Matsuoka M
Rinsho Ketsueki; 2006 Dec; 47(12):1493-501. PubMed ID: 17233467
[No Abstract] [Full Text] [Related]
22. HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development.
Maksimova V; Wilkie T; Smith S; Phelps C; Melvin C; Yu L; Niewiesk S; Green PL; Panfil AR
PLoS Pathog; 2023 Jun; 19(6):e1011459. PubMed ID: 37327244
[TBL] [Abstract][Full Text] [Related]
23. Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.
Polakowski N; Gregory H; Mesnard JM; Lemasson I
Retrovirology; 2010 Jul; 7():61. PubMed ID: 20653953
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of HTLV-1 infection and pathogenesis.
Yasunaga J; Matsuoka M
Int J Hematol; 2011 Nov; 94(5):435-42. PubMed ID: 21953273
[TBL] [Abstract][Full Text] [Related]
25. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
[TBL] [Abstract][Full Text] [Related]
26. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
Matsuoka M; Jeang KT
Oncogene; 2011 Mar; 30(12):1379-89. PubMed ID: 21119600
[TBL] [Abstract][Full Text] [Related]
27. Does chronic infection in retroviruses have a sense?
Barbeau B; Mesnard JM
Trends Microbiol; 2015 Jun; 23(6):367-75. PubMed ID: 25701112
[TBL] [Abstract][Full Text] [Related]
28. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
Satou Y; Yasunaga J; Yoshida M; Matsuoka M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
[TBL] [Abstract][Full Text] [Related]
29. Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.
Harrod R
Retrovirology; 2019 Sep; 16(1):25. PubMed ID: 31492165
[TBL] [Abstract][Full Text] [Related]
30. The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.
Choudhary G; Ratner L
Virology; 2011 Feb; 410(2):307-15. PubMed ID: 21176937
[TBL] [Abstract][Full Text] [Related]
31. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
[TBL] [Abstract][Full Text] [Related]
32. Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.
Michael B; Nair AM; Datta A; Hiraragi H; Ratner L; Lairmore MD
Virology; 2006 Oct; 354(2):225-39. PubMed ID: 16890266
[TBL] [Abstract][Full Text] [Related]
33. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.
Yamamoto B; Li M; Kesic M; Younis I; Lairmore MD; Green PL
Retrovirology; 2008 May; 5():38. PubMed ID: 18474092
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
35. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
36. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.
Kinosada H; Yasunaga JI; Shimura K; Miyazato P; Onishi C; Iyoda T; Inaba K; Matsuoka M
PLoS Pathog; 2017 Jan; 13(1):e1006120. PubMed ID: 28046066
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of HTLV-1 HBZ post-translational modifications.
Dissinger N; Shkriabai N; Hess S; Al-Saleem J; Kvaratskhelia M; Green PL
PLoS One; 2014; 9(11):e112762. PubMed ID: 25389759
[TBL] [Abstract][Full Text] [Related]
38. The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.
Rushing AW; Hoang K; Polakowski N; Lemasson I
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769340
[TBL] [Abstract][Full Text] [Related]
39. HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
Martinez MP; Cheng X; Joseph A; Al-Saleem J; Panfil AR; Palettas M; Dirksen WP; Ratner L; Green PL
Retrovirology; 2019 Dec; 16(1):44. PubMed ID: 31864373
[TBL] [Abstract][Full Text] [Related]
40. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ.
Clerc I; Polakowski N; André-Arpin C; Cook P; Barbeau B; Mesnard JM; Lemasson I
J Biol Chem; 2008 Aug; 283(35):23903-13. PubMed ID: 18599479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
